{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-102917","form_type":"8-K","ticker":"QNRX","cik":"0001671502","company_name":"Quoin Pharmaceuticals, Ltd.","filed_at":"2026-08-28T14:31:00+00:00","discovered_at":"2026-08-28T14:32:00.348699+00:00","generated_at":"2026-08-28T14:32:14.383571+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Quoin reports positive QRX003 interim data, raises up to $50M in private placement","bullets":["Private placement up to $50M: $30.8M upfront at $4.88/ADS+warrant, 6,305,300 ADSs and warrants for 3,152,650 ADSs.","Net proceeds ~$29M at Aug 31 close; funds into 2H 2029; proceeds for QRX003 development and general corporate.","Phase 2/3 CL-QRX003-004: 4/6 (66.7%) met primary endpoint (≥1-grade IGA improvement), p=0.0087 vs α=0.0215.","Secondary GIC endpoint significant (p=0.007); no treatment-related SAEs; recruitment done by end 2026, topline 2Q 2027.","Exchange agreements: issued 222,574 ADSs to settle ~$1.146M accrued interest on 2020 notes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-102917","json":"https://secwatch.observer/filing/0001104659-26-102917.json","markdown":"https://secwatch.observer/filing/0001104659-26-102917.md","text":"https://secwatch.observer/filing/0001104659-26-102917.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926102917/0001104659-26-102917-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926102917/tm2624258d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-28T14:32:14.383571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}